Loperamide for Animals

Loperamide

Loperamide is an opioid-receptor agonist used mainly for its peripheral gastrointestinal effects. It reduces propulsive motility and has an antisecretory action, providing a symptomatic role in selected diarrheal disorders. Veterinary use is largely empirical and most often involves dogs. Transporter-mediated restriction of brain exposure contributes to its usual peripheral pharmacologic profile.

Group

Peripheral opioid antidiarrhoeal

Mechanism of Action

Loperamide activates mu-opioid receptors in the intestinal wall, reducing excitatory neurotransmitter release, propulsive contractions and secretory activity. Increased transit time and segmentation can enhance fluid and electrolyte absorption. P-glycoprotein normally limits central nervous system exposure, so the expected effect is predominantly intestinal. Longer intestinal residence and reduced secretion can produce firmer stools.

Dose Rates

Dogs

Use / stageDoseRouteScheduleInstructions
Symptomatic diarrhoea0.12 mg/kgPOEvery 8–12 hDo not use in: ABCB1-associated opioid sensitivity
Symptomatic diarrhoea0.08 mg/kgPOEvery 8 hUp to 5 days; Do not use in: ABCB1-associated opioid sensitivity, Suspected invasive enteric infection; Short-term use; do not mask infection or ileus.
Symptomatic diarrhoea0.1–0.2 mg/kgPOEvery 8–12 hUp to 5 days; Do not use in: ABCB1-associated opioid sensitivity, Suspected invasive enteric infection; Short-term use; do not mask infection or ileus.
Symptomatic diarrhoea0.1 mg/kgPOEvery 8 hUp to 5 days; Do not use in: ABCB1-associated opioid sensitivity, Suspected invasive enteric infection; Short-term use; do not mask infection or ileus.
Symptomatic diarrhoea0.08 mg/kgPOEvery 6–8 hUp to 5 days; Do not use in: ABCB1-associated opioid sensitivity, Suspected invasive enteric infection; Short-term use; do not mask infection or ileus.
Symptomatic diarrhoea0.1–0.2 mg/kgPOEvery 6–12 hUp to 5 days; Do not use in: ABCB1-associated opioid sensitivity, Suspected invasive enteric infection; Short-term use; do not mask infection or ileus.
Chemotherapy-associated diarrhoea0.08 mg/kgPOEvery 8 hDo not use in: ABCB1-associated opioid sensitivity

Cats

Use / stageDoseRouteScheduleInstructions
Symptomatic diarrhoea0.08–0.16 mg/kgPOEvery 12 h
Symptomatic diarrhoea0.04–0.06 mg/kgPOEvery 12 hFeline opioid antidiarrhoeal use is controversial; excitement may occur.

Rabbits

Use / stageDoseRouteScheduleInstructions
Staged diarrhoea treatmentReference onlyPO0.1 mg/kg every 8 hours for 3 days, then once daily for 2 days; the staged schedule must remain explicit. The described dose is delivered in 1 mL water.

Mice

Use / stageDoseRouteScheduleInstructions
Staged diarrhoea treatmentReference onlyPO0.1 mg/kg every 8 hours for 3 days, then once daily for 2 days; the staged schedule must remain explicit. The described dose is delivered in 1 mL water.

Rats

Use / stageDoseRouteScheduleInstructions
Staged diarrhoea treatmentReference onlyPO0.1 mg/kg every 8 hours for 3 days, then once daily for 2 days; the staged schedule must remain explicit. The described dose is delivered in 1 mL water.

Gerbils

Use / stageDoseRouteScheduleInstructions
Staged diarrhoea treatmentReference onlyPO0.1 mg/kg every 8 hours for 3 days, then once daily for 2 days; the staged schedule must remain explicit. The described dose is delivered in 1 mL water.

Hamsters

Use / stageDoseRouteScheduleInstructions
Staged diarrhoea treatmentReference onlyPO0.1 mg/kg every 8 hours for 3 days, then once daily for 2 days; the staged schedule must remain explicit. The described dose is delivered in 1 mL water.

Guinea pigs

Use / stageDoseRouteScheduleInstructions
Staged diarrhoea treatmentReference onlyPO0.1 mg/kg every 8 hours for 3 days, then once daily for 2 days; the staged schedule must remain explicit. The described dose is delivered in 1 mL water.

Chinchillas

Use / stageDoseRouteScheduleInstructions
Staged diarrhoea treatmentReference onlyPO0.1 mg/kg every 8 hours for 3 days, then once daily for 2 days; the staged schedule must remain explicit. The described dose is delivered in 1 mL water.

Indications

  • Short-term symptomatic treatment of selected acute nonspecific diarrhea in dogs, with limited controlled veterinary efficacy evidence.
  • Specialist symptomatic management of selected treatment-associated diarrhea in dogs, including some anticancer-drug-associated cases.

Contraindications

  • ABCB1-associated opioid sensitivity
  • Avoid when decreased intestinal motility would be harmful.
  • Suspected enteric infection, obstructive/acute abdominal disease or hepatic encephalopathy requires particular caution; central excitation can occur in cats.

Interactions

  • P-glycoprotein inhibitors such as ketoconazole can increase central nervous system penetration.

Adverse effects

  • Constipation and ileus
  • Profound sedation or central depression in susceptible dogs

Toxicity

Naloxone can reverse central opioid effects; support ventilation when needed and watch for recurrent toxicity.

Preparations

PreparationFormStrengthRoute
Loperamide 2 mg tabletTablet2 mg / tabletPO
Loperamide 2 mg capsuleCapsule2 mg / capsulePO
Loperamide 0.2 mg/mL oral liquidOral Liquid0.2 mg / mLPO
Loperamide 1 mg/7.5 mL oral liquidOral Liquid1 mg / 7.5 mLPO

Monitoring and Administration

Assess the cause of diarrhoea and hydration. Avoid prolonged treatment.

Small dogs and collie-related breeds merit particular caution; do not infer safety from a usual peripheral mechanism.

Scroll to Top